AVENTUS™ TRIAL

A prospective, multi-center, single-arm, non-blinded trial with primary outcome measures capturing change in RV/LV ratio and major adverse event rate.

Up to 120 patients will be enrolled at a maximum of 25 centers in the U.S. 

Led by national principal investigators, Dr. Jun Li, University Hospitals, Cleveland, OH and Dr. Saher Sabri, Medstar Georgetown University Hospital, Georgetown, DC.  

Visit https://clinicaltrials.gov/study/NCT05907564 for more information.

If you are a healthcare professional and want to learn more about this clinical trial, email clinical@inquismedical.com.